These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11419867)

  • 21. Review article: predicting response in hepatitis C virus therapy.
    Mihm U; Herrmann E; Sarrazin C; Zeuzem S
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1043-54. PubMed ID: 16611264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of patients with chronic hepatitis C virus infection and normal transaminases].
    Serfaty L
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B202-5. PubMed ID: 12180289
    [No Abstract]   [Full Text] [Related]  

  • 23. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
    Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
    Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.
    Cornberg M; Hadem J; Herrmann E; Schuppert F; Schmidt HH; Reiser M; Marschal O; Steffen M; Manns MP; Wedemeyer H
    J Hepatol; 2006 Feb; 44(2):291-301. PubMed ID: 16360972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C.
    Soza A; Hoofnagle JH
    Hepatology; 2003 Jul; 38(1):267. PubMed ID: 12830010
    [No Abstract]   [Full Text] [Related]  

  • 26. Doing battle with HCV.
    Fimmel CJ
    Am J Gastroenterol; 2000 Mar; 95(3):582-3. PubMed ID: 10710043
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin.
    Fujita N; Kaito M; Kai M; Sugimoto R; Tanaka H; Horiike S; Konishi M; Iwasa M; Watanabe S; Adachi Y
    J Viral Hepat; 2006 Jul; 13(7):441-8. PubMed ID: 16792537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating the evidence from clinical trials in chronic hepatitis C.
    Brown RS
    J Viral Hepat; 2006 May; 13 Suppl 1():15-25. PubMed ID: 16630043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First-line treatments for hepatitis C.
    Messori A; Del Santo F; Maratea D
    Aliment Pharmacol Ther; 2011 Jun; 33(12):1383-5. PubMed ID: 21569068
    [No Abstract]   [Full Text] [Related]  

  • 30. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.
    Antúnez I; Aponte N; Fernández-Carbia A; Rodríguez-Perez F; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C: not so indolent in survivors of pediatric cancer?
    Schwarz KB
    Pediatr Blood Cancer; 2010 Jul; 55(1):7. PubMed ID: 20486163
    [No Abstract]   [Full Text] [Related]  

  • 32. [Similar poor response in genotype 4 chronic Hepatitis C treatment with interferon and ribavirin compared with genotype 1 treatment].
    Pérez Mota A; Graus J; García Flores MA; Blanco M; Pérez-Muñoz C; Villalgordo C; Rodero R
    Rev Esp Enferm Dig; 2003 Mar; 95(3):238-9. PubMed ID: 12760714
    [No Abstract]   [Full Text] [Related]  

  • 33. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.
    Naito M; Matsui A; Inao M; Nagoshi S; Nagano M; Ito N; Egashira T; Hashimoto M; Mishiro S; Mochida S; Fujiwara K
    J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of chronic hepatitis C in patients with HIV coinfection: efficacy and tolerance].
    Pol S
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B264-73. PubMed ID: 12180300
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hepatitis C treatment without liver biopsy].
    Siboni A
    Ugeskr Laeger; 2002 Mar; 164(11):1522-3; discussion 1523-4. PubMed ID: 11924484
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C.
    Hofer H; Osterreicher C; Jessner W; Penz M; Steindl-Munda P; Wrba F; Ferenci P
    J Hepatol; 2004 Jun; 40(6):1018-22. PubMed ID: 15158344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up to date treatment of hepatitis C in adults.
    Schalm SW; Brouwer JT
    Acta Gastroenterol Belg; 1998; 61(4):397-9. PubMed ID: 9923088
    [No Abstract]   [Full Text] [Related]  

  • 38. Effectiveness of conventional interferon and ribavirin combination therapy in chronic Hepatitis C patients in Pakistan.
    Bukhsh A; Goh BH; Lee LH; Khan TM
    J Infect Public Health; 2017; 10(5):692-693. PubMed ID: 28209323
    [No Abstract]   [Full Text] [Related]  

  • 39. Combination treatment for hepatitis C is not being given.
    Foster GR; Chapman R
    BMJ; 2000 Oct; 321(7265):899. PubMed ID: 11021891
    [No Abstract]   [Full Text] [Related]  

  • 40. [Interferons and chronic hepatitis C treatment].
    Cai DC; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):847-8. PubMed ID: 18073070
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.